NEU neuren pharmaceuticals limited

Ann: Annual Report to shareholders, page-18

  1. 996 Posts.
    lightbulb Created with Sketch. 174
    Silent,
    Just to clarify Neuren received Orphan Drug status but was denied Breakthrough therapy designation by the FDA. From my very limited knowledge these are two very different FDA approvals.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.08
Change
0.230(1.79%)
Mkt cap ! $1.628B
Open High Low Value Volume
$13.15 $13.37 $12.92 $5.195M 395.9K

Buyers (Bids)

No. Vol. Price($)
6 549 $13.07
 

Sellers (Offers)

Price($) Vol. No.
$13.09 547 4
View Market Depth
Last trade - 13.57pm 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.